MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-24-0039057
Codex Drugs Private Limited
Codex Drugs Private Limited - chemicals in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹88,241
▼ 29% YoY
Net loss · FY 2025
₹1.69 Lakh
Net margin -192%
EBITDA · FY 2025
-₹1.52 Lakh
EBITDA margin -172.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Codex Drugs Private Limited
Data last updated:
Codex Drugs Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 27 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24233GJ2007PTC050678. Its GSTIN is 24AADCC0728R1ZH (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pradip Govindlal Doshi and Maulik Pradipkumar Doshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 207 Signet Hub B/S Bridge Akshar Chowk Mujmahuda, Vadodara, Gujarat, India – 390012.
As per the financials filed for FY 2025, the company reported a revenue of ₹88,241, a decline of 29% compared to the previous year. For the same year it recorded a net loss of ₹1.69 Lakh (net margin -192%) and EBITDA of -₹1.52 Lakh (EBITDA margin -172.7%). Revenue has declined at a compounded annual rate (CAGR) of 43% over three years and 20% over five years.
Codex Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0039057). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233GJ2007PTC050678
Registration Number 050678
Incorporation Date 27 April 2007
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-24-0039057
Recognitions & Rankings of Codex Drugs
Contact details
Codex Drugs Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address is in the company report.
- Email
- Registered Address207 Signet Hub B/S Bridge Akshar Chowk Mujmahuda, Vadodara, Gujarat, India – 390012
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Codex Drugs Private Limited, buy the company report.
Comprehensive company report
Codex Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Codex Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Codex Drugs Private Limited, buy the company report.
Financials of Codex Drugs Private Limited
FY 2025 filings availableCodex Drugs Private Limited reported revenue of ₹88,241 (down 29% YoY) for FY 2025.
Revenue · FY 2025
₹88,241 ▼ 29%
Net loss · FY 2025
₹1.69 Lakh margin -192%
EBITDA · FY 2025
-₹1.52 Lakh margin -172.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 29%
3 years · compounded
▼ 43%
5 years · compounded
▼ 20%
EBITDA CAGR growth
1 year
▼ 895%
3 years · compounded
▼ 67%
5 years · compounded
▼ 10%
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 29% fall in the latest year. EBITDA fell 895% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -172.7% | ||||
| Net Profit Margin | -192% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Codex Drugs Private Limited, buy the company report.
Board of directors of Codex Drugs Private Limited
Codex Drugs has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradip Govindlal Doshi | Director | 19 Sep 2016 | 10 Years 1 Months | Current |
| Maulik Pradipkumar Doshi | Director | 19 Sep 2016 | 10 Years 1 Months | Current |
Peer comparison
Codex Drugs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sannidhi Polymers Private Limited | ₹89,659 (FY 2023) | -74.0% | Jaipur, Rajasthan, India | |||
| Ordnc 2024 000066 U51909ur2018ptc008397 Private Limited | ₹89,640 (FY 2022) | -91.0% | Roorkee, Uttarakhand, India | |||
| Affluence Healthcare Private Limited | ₹88,791 (FY 2019) | 2642.0% | Jaipur, Rajasthan, India | |||
| Roland Health Care Private Limited | ₹88,341 (FY 2021) | -69.0% | Bareilly, Uttar Pradesh, India | |||
| Oyester Life Science Private Limited | ₹88,313 (FY 2018) | Mumbai, Maharashtra, India | ||||
| Codex Drugs Private Limitedthis company | ₹88,241 (FY 2025) | -₹1.69 Lakh | -192% | -29.0% | Vadodara, Gujarat, India | |
| Nath Ayurveda Private Limited | ₹87,402 (FY 2025) | -92.0% | Rajpura, Punjab, India | |||
| Medidel Pharma Private Limited | ₹87,298 (FY 2024) | -87.0% | Madha, Maharashtra, India | |||
| Svashmi Genotech Private Limited | ₹87,000 (FY 2023) | -9.0% | Bangalore, Karnataka, India | |||
| Smile Natural Care Private Limited | ₹86,930 (FY 2020) | -77.0% | Solan, Himachal Pradesh, India | |||
| Chian Bio Private Limited | ₹86,730 (FY 2025) | -78.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Codex Drugs Private Limited, buy the company report.
Auditor
Codex Drugs Private Limited is audited by JIGNA V. SHAH & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JIGNA V. SHAH & CO. | FY 2017 | 130178 |
Shareholding
The shareholding of Codex Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Codex Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Codex Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Codex Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Codex Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCC0728R1ZH | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Codex Drugs Private Limited, buy the company report.
Recent activity
Codex Drugs Private Limited has 12 board changes on record since 2007: 7 appointments and 5 cessations. The latest: Bhasker Kishorkant Gandhi ceased to be Director on 21 Sep 2016.
AGM
Codex Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Codex Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Bhasker Kishorkant Gandhi ceased to be Director.
Ceased
Dineshchandra Govindlal Doshi ceased to be Director.
Appointed
Maulik Pradipkumar Doshi was appointed as Director.
Appointed
Pradip Govindlal Doshi was appointed as Director.
Ceased
Ravindra S Akolkar ceased to be Director.
Ceased
Hardikkumar Ashwinkumar Shah ceased to be Director.
Appointed
Ravindra S Akolkar was appointed as Director.
Ceased
Vishal Paresh Parikh ceased to be Director.
Appointed
Bhasker Kishorkant Gandhi was appointed as Director.
Appointed
Dineshchandra Govindlal Doshi was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Codex Drugs is an active private limited company based in Vadodara, Gujarat, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 27 April 2007 (19+ years old) and is registered under CIN U24233GJ2007PTC050678.
Codex Drugs has 2 current directors:
- Pradip Govindlal Doshi - Director
- Maulik Pradipkumar Doshi - Director
The latest financial statements of Codex Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Codex Drugs is 24AADCC0728R1ZH, registered in Gujarat.
The CIN (Corporate Identification Number) of Codex Drugs is U24233GJ2007PTC050678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Codex Drugs was incorporated on 27 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Codex Drugs by revenue are Sannidhi Polymers Private Limited, Ordnc 2024 000066 U51909ur2018ptc008397 Private Limited, Affluence Healthcare Private Limited, Roland Health Care Private Limited, Oyester Life Science Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhasker Kishorkant Gandhi ceased to be Director on 21 Sep 2016. Dineshchandra Govindlal Doshi ceased to be Director on 19 Sep 2016. Maulik Pradipkumar Doshi was appointed as Director on 19 Sep 2016. Codex Drugs has 12 board changes on record in total.
Yes, Codex Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-24-0039057).
The registered office of Codex Drugs is at 207 Signet Hub BS Bridge Akshar Chowk Mujmahuda, Vadodara, Gujarat, India – 390012.
Codex Drugs operates in the chemicals industry, in the medicinal chemical and botanical products segment.